Strategically Comprehensive Immunotherapy Employing Modified Antibody Targeting NY-ESO-1 for Multiple Myeloma

被引：0
|
作者：
Maruta, Masaki [1 ]
Tanimoto, Kazushi [1 ]
Azuma, Taichi [1 ]
Fujiwara, Hiroshi [1 ]
Yasukawa, Masaki [1 ]
机构：
[1] Ehime Univ, Sch Med, Dept Int Med 1, Matsuyama, Ehime, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Immune cell therapy; Multiple myeloma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2374
引用
收藏
页码：757 / 757
页数：1
相关论文
共 50 条
  • [21] NY-ESO-1: a promising cancer testis antigen for sarcoma immunotherapy and diagnosis
    Smith, Stephen M.
    Iwenofu, O. Hans
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (04)
  • [22] T Cells Targeting NY-ESO-1 and Melan-A Are Prognostic in Melanoma
    不详
    CANCER DISCOVERY, 2012, 2 (06)
  • [23] PROMOTER DEMETHYLATION OF NY-ESO-1 PRIMES GLIOBLASTOMA FOR IMMUNOTHERAPEUTIC TARGETING.
    Lai, Thomas
    Treger, Janet
    Rao, Jingyou
    Sun, Lu
    Li, Tie
    Lai, Albert
    Prins, Robert
    Everson, Richard G.
    NEURO-ONCOLOGY, 2022, 24 : 133 - 134
  • [24] A Novel Murine T-Cell Receptor Targeting NY-ESO-1
    Rosati, Shannon F.
    Parkhurst, Maria R.
    Hong, Young
    Zheng, Zhili
    Feldman, Steven A.
    Rao, Mahadev
    Abate-Daga, Daniel
    Beard, Rachel E.
    Xu, Hui
    Black, Mary A.
    Robbins, Paul F.
    Schrump, David A.
    Rosenberg, Steven A.
    Morgan, Richard A.
    JOURNAL OF IMMUNOTHERAPY, 2014, 37 (03) : 135 - 146
  • [25] Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis
    Yang, Jihua
    Jiao, Shunchang
    Kang, Jingbo
    Li, Rong
    Zhang, Guanzhong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14959 - 14964
  • [26] NY-ESO-1 TCR single edited t cells to treat multiple myeloma without inducing GvHD
    Mastaglio, S.
    Genovese, P.
    Magnani, Z.
    Landoni, E.
    Camisa, B.
    Schiroli, G.
    Provasi, E.
    Lombardo, A.
    Reik, A.
    Cieri, N.
    Rocchi, M.
    Oliveira, G.
    Escobar, G.
    Casucci, M.
    Gentner, B.
    Spinelli, A.
    Mondino, A.
    Bondanza, A.
    Vago, L.
    Ponzoni, M.
    Ciceri, F.
    Holmes, M.
    Naldini, L.
    Bonini, C.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S102 - S102
  • [27] SYSTEMIC ADOPTIVE TRANSFER IMMUNOTHERAPY WITH TCR-TRANSDUCED T-CELLS TARGETING NY-ESO-1 FOR MENINGIOMA
    Sun, Matthew
    Orpilla, Joey
    Contreras, Erick
    Treger, Janet
    Molaie, Donna
    Tsang, Jonathan
    Antonios, Joseph
    Wang, Anthony
    Liau, Linda
    Prins, Robert
    Everson, Richard
    NEURO-ONCOLOGY, 2019, 21 : 129 - 130
  • [28] Antibody-CpG conjugate for immunotherapy using NY-ESO-1 intracellular tumor-associated antigen target
    Abou, D. S.
    Noguchi, T.
    Ritter, G.
    Lewis, J. S.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 : 1 - 1
  • [29] Screening for the cancer immunotherapy target NY-ESO-1 in soft-tissue sarcoma
    Sellner, L.
    Chudasama, P.
    Renner, M.
    Gong, W.
    Heilig, C. E.
    Egerer, G.
    Shiku, H.
    Mechtersheimer, G.
    Mueller-Tidow, C.
    Froehling, S.
    Gdynia, G.
    Schmitt, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 111 - 111
  • [30] T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma
    Singh, Nathan
    Kulikovskaya, Irina
    Barrett, David M.
    Binder-Scholl, Gwendolyn
    Jakobsen, Bent
    Martinez, Daniel
    Pawel, Bruce
    June, Carl H.
    Kalos, Michael D.
    Grupp, Stephan A.
    ONCOIMMUNOLOGY, 2016, 5 (01):
12345